The invention relates to compounds of Formula A: (A) or a pharmaceutically acceptable salt,solvate, hydrate, or prodrug thereof. The compounds of Formula A are TGR5 modulatorsuseful for the treatment of various diseases, including obesity, insulin sensitivity,inflammation, cholestasis, and bile desaturation.